These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33152268)

  • 1. Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε.
    Sviderskiy VO; Blumenberg L; Gorodetsky E; Karakousi TR; Hirsh N; Alvarez SW; Terzi EM; Kaparos E; Whiten GC; Ssebyala S; Tonzi P; Mir H; Neel BG; Huang TT; Adams S; Ruggles KV; Possemato R
    Mol Cell; 2020 Nov; 80(4):682-698.e7. PubMed ID: 33152268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.
    Baker LA; Holliday H; Roden D; Krisp C; Wu SZ; Junankar S; Serandour AA; Mohammed H; Nair R; Sankaranarayanan G; Law AMK; McFarland A; Simpson PT; Lakhani S; Dodson E; Selinger C; Anderson L; Samimi G; Hacker NF; Lim E; Ormandy CJ; Naylor MJ; Simpson K; Nikolic I; O'Toole S; Kaplan W; Cowley MJ; Carroll JS; Molloy M; Swarbrick A
    Breast Cancer Res; 2020 Jun; 22(1):63. PubMed ID: 32527287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.
    Lawson CD; Fan C; Mitin N; Baker NM; George SD; Graham DM; Perou CM; Burridge K; Der CJ; Rossman KL
    Cancer Res; 2016 Jul; 76(13):3826-37. PubMed ID: 27216196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells.
    Rogers RF; Walton MI; Cherry DL; Collins I; Clarke PA; Garrett MD; Workman P
    Cancer Res; 2020 Apr; 80(8):1735-1747. PubMed ID: 32161100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation.
    Hughes BT; Sidorova J; Swanger J; Monnat RJ; Clurman BE
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8954-9. PubMed ID: 23671119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
    Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
    Laine A; Nagelli SG; Farrington C; Butt U; Cvrljevic AN; Vainonen JP; Feringa FM; Grönroos TJ; Gautam P; Khan S; Sihto H; Qiao X; Pavic K; Connolly DC; Kronqvist P; Elo LL; Maurer J; Wennerberg K; Medema RH; Joensuu H; Peuhu E; de Visser K; Narla G; Westermarck J
    Cancer Res; 2021 Aug; 81(16):4319-4331. PubMed ID: 34145035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells.
    Soung YH; Pruitt K; Chung J
    Sci Rep; 2014 Jan; 4():3846. PubMed ID: 24457910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human DNA polymerase ε is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19.
    Moiseeva TN; Gamper AM; Hood BL; Conrads TP; Bakkenist CJ
    DNA Repair (Amst); 2016 Jul; 43():9-17. PubMed ID: 27235625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells.
    Patel P; Tsiperson V; Gottesman SRS; Somma J; Blain SW
    Mol Cancer Res; 2018 Mar; 16(3):361-377. PubMed ID: 29330290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer.
    Aziz D; Lee C; Chin V; Fernandez KJ; Phan Z; ; ; Waring P; Caldon CE
    J Pathol Clin Res; 2022 Jul; 8(4):355-370. PubMed ID: 35384378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer.
    Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X
    Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.
    Corsino PE; Davis BJ; Nørgaard PH; Parker NN; Law M; Dunn W; Law BK
    Neoplasia; 2008 Nov; 10(11):1240-52. PubMed ID: 18953433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
    Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
    Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.